FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: DRUGS · 22 October 2026

Northland Nuclear Medicine, LLC - 736893 - 10/22/2026

Synopsis

Food and Drug Administration (FDA) inspection of your facility. Your firm failed to ensure adequate control of airflow in the ISO 5 critical aseptic processing area.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: drugs ↗

More in New medicines and drug discovery